ACCREDITATION STATUS:

UKAS Schedule of Accreditation, Accredited to ISO/IEC 17043:2010 Provider 8351

CLINICAL APPLICATION:

Interpretation of HFE genotyping and HH

PURPOSE OF PROGRAMME:

To assess participants' ability to make an accurate, clear and concise clinical report, appropriate for the range of clinical staff involved in a patient's care and treatment, given HFE genotype and other relevant clinical information.

ANALYTES:

PROGRAMME OF ANALYSIS:

Results should be submitted via online data entry within the specified reporting period (please refer to results deadline for each distribution on the UK NEQAS for H&I website or Participants Manual)

DATA ANALYSIS:

Not applicable.

PERFORMANCE SCORING:

For each of the patient scenarios several interpretative criteria expected to be covered by the report, will be identified and agreed by the Expert Advisors. Full or half penalty points may be awarded for interpretative criterion not covered by the report

PERFORMANCE MONITORING:

Satisfactory performance is obtaining 4 'Acceptable' classifications in a year

PERSISTENT POOR PERFORMANCE:

Unsatisfactory Performance Notifications are not sent to participants of Interpretative Schemes